Irinotecan and Temozolomide for Ewing Sarcoma
Clinical trial NCT03359005 · UNKNOWN
Trial details
- NCT number
- NCT03359005
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2022-11-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.